Gary A. Lyons sold $1.49M worth of shares in Neurocrine Biosciences Inc. in June 2018

Jul 08, 2018
Insider Transactions
Background Information
Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.